Grifols | GRFS - Market Capitalization

Stock Price
8.24
Daily Change
0 0%
Monthly
-5.94%
Yearly
25.80%
Q2 Forecast
8.00

Grifols reported EUR2.12B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 5M Sep/2025
Arca Biopharma USD 1.47B 537M Dec/2025
Bio Path USD 1000K 0 Sep/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Esperion Therapeutics USD 885M 351M Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Infinity Pharmaceuticals USD 0 0 Apr/2026
Nektar Therapeutics USD 14.34B 13.48B Apr/2026